Varaico: Literature-Extracted Genetic Variants

Gene:PMM2
Variant:p.E151G
Back to variants list

PMM2

NM_000303.3:p.E151G

Associated Papers

Contribution of rare coding variants to microcephaly in individuals with neurodevelopmental disorders.

Yoon JG et al.

Genome Medicine, 2025

40770811 (PubMed )
Supplement: 13073_2025_1513_MOESM2_ESM.xlsx › ST3

Dynamicasome-a molecular dynamics-guided and AI-driven pathogenicity prediction catalogue for all genetic mutations.

Islam NN et al.

Communications Biology, 2025

40624350 (PubMed )
Supplement: 42003_2025_8334_MOESM3_ESM.zip › PMM2-mutation-prediction-with-AI › Latest_AllModel_WithOutSide_Program_May10th_2024.xlsx › Sheet1

Insight on molecular pathogenesis and pharmacochaperoning potential in phosphomannomutase 2 deficiency, provided by novel human phosphomannomutase 2 structures.

Briso-Montiano A et al.

Journal of Inherited Metabolic Disease, 2022

Identification of potential inhibitors against pathogenic missense mutations of PMM2 using a structure-based virtual screening approach.

Thirumal Kumar D et al.

Journal of Biomolecular Structure & Dynamics, 2021

Congenital disorder of glycosylation type 1a: three siblings with a mild neurological phenotype.

Coman D et al.

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 2007

Congenital disorder of glycosylation type Ia in a 6-year-old girl with a mild intellectual phenotype: two novel PMM2 mutations.

Coman D et al.

Journal of Inherited Metabolic Disease, 2005

DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG).

Schollen E et al.

European Journal of Human Genetics : Ejhg, 2002

High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).

Grünewald S et al.

American Journal of Human Genetics, 2001

Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).

Matthijs G et al.

Human Mutation, 2000

Carbohydrate-deficient glycoprotein syndrome type 1a: a variant phenotype with borderline cognitive dysfunction, cerebellar hypoplasia, and coagulation disturbances.

van Ommen CH et al.

The Journal of Pediatrics, 2000

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."